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Summary Glutathione S-transferase (GST) isoenzyme expression is altered in a variety of neoplasms and the
enzymes are implicated in metabolism of carcinogens and resistance to drugs, including cisplatin. We have
studied GST Alpha, Pi, Mu and microsomal isoenzyme expression by immunohistochemistry in normal and
cryptorchid testes, intratubal germ cell neoplasia (ITGCN), seminoma and non-seminomatous germ cell
tumours. In 16 stage II-IV malignant teratoma intermediate (MTI) both orchidectomy and post-treatment
residual surgical masses were studied.
All four isoenzymes were strongly expressed in Leydig and Sertoli cells. GST Pi was absent from normal
spermatogonia but strongly expressed by the neoplastic germ cells of ITGCN and seminoma. GST Pi was
strongly expressed in all elements of teratoma, irrespective of differentiation. There were no qualitative
differences in expression between primary and post-chemotherapy metastases. GST Alpha expression in
teratoma correlated with epithelial differentiation. GSTs may be important in normal spermatogenesis and
protection of germ cells from teratogens and carcinogens. They may have a role in testicular tumour drug
resistance but this role is not well defined. GST Pi is a new marker for ITGCN.
The glutathione S-transferase (GSTs) play a central role in
the cellular metabolism of cytoxic and carcinogenic com-
pounds (Chasseaud, 1979; Mannervik, 1985). This role is
fulfilled either by catalysing the conjugation of glutathione
(GSH) with electrophilic species (Mannervik & Danielson,
1988) or by reducing reactive organic peroxides (Kramer et
al., 1988). The GSTs comprise at least five gene families
represented by the four cytosolic classes, (Mannervik et al.,
1985) Alpha, Mu, Theta and Pi, and at least one distinct
membrane-associated microsomal class (Morgenstern et al.,
1990). The distribution of GST isoenzymes in human tissues
is not uniform and altered expression of GSTs has been
demonstrated in a variety of tumour tissues (Howie et al.,
1990). GST Pi acts as a marker of preneoplasia in animal
models (Sato et al., 1987) and has been implicated in the
acquisition of a drug resistant phenotype during car-
cinogenesis (Batist et al., 1986).
The treatment of advanced testicular germ cell tumours
has been revolutionised by the introduction ofcisplatin based
multiagent chemotherapy regimes (Einhorn & Williams,
1980). However, a proportion of tumours are refractory to
treatment and mechanisms of drug resistance in those cases
are poorly understood. The GSH/GST system is involved in
the metabolism of cisplatin and carboplatin (Declon &
Borch, 1987) and high levels of GST Pi mRNA in human
lung cancer cell lines are associated with cisplatin resistance
(Nakagawa et al., 1988). GSTs may also confer resistance to
bleomycin and other cytotoxic drugs (Waxman, 1990) which
act partly by generation of reactive oxygen species.
Most, if not all, germ cell tumours appear to arise from an
in situ phase, intratubal germ cell neoplasia (ITGCN) (Gon-
dos & Migliozzi, 1987). The most important association of
ITGCN and invasive tumours is with cryptorchidism (Batata
et al., 1982) but no carcinogens have been directly implicated
in human testicular cancer. GSTs form a major part of
testicular peroxidase activity (Lawrence & Burk, 1978). In the
seminiferous tubule GST activity is much higher in Sertoli
cells (Voganathan et al., 1989a) than in germ cells and GST
Pi mRNA is confined to the Sertoli cell in the rat testis
(Voganathan et al., 1989b). It is suggested that this enzyme
group protects the germ cell from free radical damage
(Voganathan et al., 1989a) and the effects of carcinogens and
mutagens.
In this study GST isoenzyme expression was examined by
immunohistochemistry, in normal and cryptorchid testes,
ITGCN, seminoma and non-seminomatous germ cell tu-
mours. We include a group of teratoma cases in which pre-
and post-chemotherapy tissues were available.
Materials and methods
Cases
A total of 62 cases were studied. These were formalin-fixed,
paraffin embedded biopsies from archives (1977-1990) where
clinical follow-up data were available. These included 5 nor-
mal testes, seven cryptorchid testes and 11 cases of ITGCN.
Thirty-nine cases of invasive germ cell tumours were studied
composed of 22 malignant teratoma intermediate (MTI),
eight malignant teratoma undifferentiated (MTU), six
seminoma and three yolk sac tumours (British classification)
(Pugh & Cameron, 1976, pp. 202-204). The age range of the
tumour cases at time of diagnosis was 15-51 years. The
normal testes were of histologically normal cases in males of
50 years and over, who had not received any hormonal
therapy. In 16 stage II-IV MTI (Royal Marsden Hospital
stage) (Heydig et al., 1980) both orchidectomy specimens and
post-treatment residual surgical masses were available for
study (Table I).
Immunostaining
Polyclonal antisera raised in the rabbit to GST Pi, Mu,
Alpha and microsomal classes were the kind gift of Dr J.D.
Hayes, University Department of Clinical Biochemistry,
Edinburgh. Isoenzyme preparation, rabbit immunisation and
characterisation of antibodies have been previously described
(Morgenstern et al., 1990; Hayes et al., 1983; Hayes et al.,
1987; Hayes et al., 1986).
Sections of formalin-fixed, paraffin-embedded tissues were
cut at 3 fsm, dewaxed in xylene and incubated with primary
antibody at a dilution of 1:200 in phosphate buffered saline
for a period of one hour at 20°C. Detection was by
biotinylated swine anti-rabbit immunoglobulin (Dako) and
streptavidin-biotin-peroxidase complex (Dako). Visualisation
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Case presentation Treatment Status (months)
1 IVL1 BEP x 4 DIED 8
2 IR B BPV/E x 4 A+W 72
3 II B BEPx4 A+W 48
4 IIC BVP/E x 4 A+W 66
5 II C BPV/E x 4 A+W 62
6 II A BEPx4 A+W 62
7 IV H + PVB x 5 DIED 25
8 II A PVB x 6 DIED 17
9 II A PVB x 5 DIED 10
10 II B BPV/E x 6 A+W 36
11 IV CL2 PVBEM x 6 A+W 60
12 IIC BEPx6 A+W 13
13 III A BPV/E x 4 A+W 59
14 IV CL2 BEP x 5 A+W 55
15 III C PBVEM x 6 A+W 55
16 IIC BEPx4 A+W 94
B = Bleomycin, E = Etoposide, V = Vinblastine, P = Cisplatin,
M = Methotrexate, A + W = Alive and well.
using 3,3,-diaminobenzidine as substrate produced a brown
insoluble precipitate. Sections were lightly counterstained
with haematoxylin. Liver tissue was used as a control, GST
Pi staining bile duct epithelium and GST Alpha, Mu and
microsomal classes staining hepatocytes.
Results
Normal and cryptorchid testes
Sertoli cells and Leydig cells showed strong positive cytoplas-
mic staining for GST Pi, Alpha, Mu and microsomal classes
in all 5 normal testes. GST Pi was also present in nuclei
(Figure 1). Spermatogonia and primary spermatocytes were
negative in all normal testes. Faint reactivity of secondary
spermatocytes and spermatids for GST Pi and Mu classes
was seen in each case. In seven testes where histologically
normal epididymal tissues were present, the epididymal lining
epithelium was strongly positive for both GST Pi and Alpha.
Six cases were positive for GST Mu and four for GST
microsomal class.
In the seven cryptorchid testes there was a similar pattern
of Leydig and Sertoli cell GST expression to the normal
testis but the intensity appeared stronger (Figure 2).
ITGCN
The neoplastic germ cells in 11 cases of ITGCN showed
strong nuclear and peripheral cytoplasmic staining for GST
Fge 1 GST Pi isoenzyme expression in the normal testis.
There is strong staining of Leydig cells with weaker positivity in
Sertoli cells. (arrows) (bar = 50jum)
Figure 2 Intense staining for GST Pi isoenzyme in the Leydig
cells and Sertoli cells of the cryptorchid testis. (bar = 500jm)
Pi (Figure 3). Faint staining for GST Alpha was present in
six cases. GST Mu positivity was present in five cases and
GST microsomal in four cases.
Seminoma
GST Pi was strongly expressed in all eight cases (Figure 4)
with occasional negative cells and showed a similar cellular
distribution to ITGCN. GST Alpha was positively expressed
in seven cases, GST Mu in five cases, and GST microsomal
in four cases.
Teratoma
All well differentiated epithelial elements ofthe 6 stage I MTI
and 16 stage II-IV MTI testes showed strong expression of
GST Pi (Figure 5a) and Alpha classes (Figure 5b). Mesen-
chymal elements (cartilage and smooth muscle), where pres-
ent, were uniformly negative for GST Alpha class but
strongly positive for GST Pi class (Figure 5).
Undifferentiated elements (embryonal carcinoma) showed
strong diffuse predominantly nuclear positivity for GST Pi in
all cases. GST Alpha was negative for undifferentiated
elements in three of 22 cases of MTI. In 19 positive cases of
MTI the undifferentiated elements showed a weak back-
ground positivity with strong focal staining for GST Alpha
related to areas of tubular and papillary differentiation
(Figure 6). GST Mu and microsomal were positive in all
cases of MTI but did not show any consistent relation to
epithelial or mesenchymal differentiation.
There was no significant difference between staining pat-
Figure 3 GST Pi isoenzyme expression in the neoplastic germ
cells of ITGCN. (bar = 50jim)GST ISOENZYME EXPRESSION IN HUMAN TESTIS 591
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Figure 4 Expression of the GST Pi isoenzyme in seminoma.
(bar = 50gm)
a
Figure 5 a Expression of GST Pi isoenzyme in MTI chond-
rocytes and well differentiated epithelium. (bar = 125 JLm). b Exp-
ression of GST Alpha isoenzyme in MTI well differentiated
epithelium. The chondrocytes are negative. (bar = 125 tLm)
terns for GSTs Pi and Alpha in MTI Stage I and MTI Stage
II-IV.
The pattern of expression in post-treatment metastatic
deposits of MTI Stage II-IV was similar to the primary
tumour and reflected the component elements (differentiated
epithelium, mesenchyme, embryonal carcinoma). There were
no significant differences in isoenzyme expression between
survivors and those who died of their disease.
Figure 6 Focal expression of GST Alpha isoenzyme in emb-
ryonal carcinoma (MTU) in relation to tubulo-papillary forma-
tions. (bar = 125gm)
The eight cases of MTU showed strong diffuse mainly
nuclear staining for GST Pi. GST Alpha expression was
similar to the undifferentiated elements of MTI; with focal
strong positivity associated with tubular formations. All eight
cases expressed GST Mu and four cases were positive for
GST microsomal class. Three cases of yolk sac tumour
showed positive expression of GST Pi, Alpha, Mu and
microsomal classes.
Discussion
We have demonstrated that GST Pi, Alpha, Mu and micro-
somal expression is present in and largely confined to the
Sertoli and Leydig cell compartments of the normal human
testis. Normal spermatogenesis is critically dependent on the
close association of active Sertoli cells and developing germ
cells (Ritzen et al., 1981). Sertoli cells are largely responsible
for germ cell oxido-reductive enzyme systems (Voganathan et
al., 1989a) and glutathione production (Li et al., 1989).
Testes of mature rodents contain high concentrations of
GSH (Mushawar & Koeppe, 1973) and increase in testicular
GSH parallels spermatogenic cell development (Grosshans &
Calvin, 1985). GSH protects against germ cell mutagenesis by
ethyl methanesulfonate in the F-344 rat and this is dependent
on enzymatic conjugation by GST (Teaf et al., 1985). GSTs
may be an important enzyme system in detoxification of
xenobiotics in the human testis but the role of individual
carcinogens and teratogens is largely unknown. The demon-
stration of GST expression in the epididymis parallels
previous studies in the rat testis (Hales et al., 1980). At this
site they may be important in final stages of spermatozoal
maturation and provide protection against teratogens. The
function of GSTs in the Leydig cell has not been defined.
They have a role in steroid transport and isomerisation (Lis-
towsky et al., 1988) and this may also be of importance in
the Sertoli cell. GST Alpha is present in the corresponding
cell in human ovary, the enzymatically active stromal cell
(EASC) (Rahilly et al., 1991). The nuclear distribution of
GST Pi has been previously described but its significance
remains uncertain (Rahilly et al., 1991).
We demonstrated GST Pi expression in ITGCN but not in
normal spermatogonia. This is consistent with its expression
in preneoplasia in other organs (Sato, 1989) and it shows a
striking parallel with expression of placental alkaline phos-
phatase (PLAP). This latter enzyme is expressed in fetal germ
cells, ITGCN (Hustin et al., 1987) and seminoma and is used
as a marker in routine diagnosis. GST Pi appears to reliably
distinguish ITGCN from normal spermatogonia but is not
such a specific marker. It has been shown that cisplatin-based
chemotherapy may not eradicate ITGCN in some cases
(Fossa & Aass, 1989; Chong et al., 1986) implying a drug-592 H.S. KLYS et al.
resistant phenotype and/or protection by the blood-testis bar-
rier; and this may be important in development of a second
primary tumour in the contralateral testis.
In seminoma and teratoma GST Pi was expressed in all
tumour elements, irrespective of degree or line of differ-
entiation. We were unable to demonstrate any qualitative
difference between untreated primary tumours and post-
chemotherapy metastatic deposits nor correlate expression
with survival. However, the immunohistochemical method is
relatively insensitive to changes in levels of expression and
the study was necessarily limited by the availability of tissue
from patients for whom follow-up data was available. GST
Pi expression has been correlated with cisplatin resistance in
human tumour cell lines, (Nakagawa et al., 1988; Teicher et
al., 1987) but the implications in the clinical situation are
uncertain. Raised cellular GSH levels protect against
Bleomycin cytotoxicity (Russo et al., 1984) but there is no
direct evidence of GSH/GST involvement in resistance to
vinca alkaloids or etoposide (VP-16).
We have shown that GST Alpha class expression is related
to epithelial differentiation and that in embryonal carcinoma
(MTU) expression is focal and related to tubal and papillary
formations. In post-chemotherapy surgically resected masses
differentiated elements are often the only viable component.
It is believed that this is due to selective destruction of more
primitive elements rather than chemotherapy-induced
differentiation (McCartney et al., 1984); and implies that
differentiated elements are drug resistant, even though they
behave in a less malignant fashion.
In summary GSTs are widely expressed in normal and
neoplastic testicular tissues. They may be important in
spermatogenesis and resistance to teratogens and carcinogens
in the normal testis. They show characteristic patterns of
expression in testicular tumours but their role in drug resis-
tance is not well defined. GST Pi is a new marker for
ITGCN.
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